Cover Image
市場調查報告書

病毒學市場預測:各種類、用途、終端用戶、地區

Virology Market: By Type (Diagnosing Test, Viral Infection Controlling Methods & others); By Application (Skin & Soft Tissue Infections, Respiratory Tract Infections & others); By End-User & By Region - (2015-2023)

出版商 IndustryARC 商品編碼 422720
出版日期 內容資訊 英文 131 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
病毒學市場預測:各種類、用途、終端用戶、地區 Virology Market: By Type (Diagnosing Test, Viral Infection Controlling Methods & others); By Application (Skin & Soft Tissue Infections, Respiratory Tract Infections & others); By End-User & By Region - (2015-2023)
出版日期: 2017年09月15日 內容資訊: 英文 131 Pages
簡介

本報告提供病毒學市場相關調查,推動、阻礙市場要素和市場機會,各種類、用途、終端用戶、地區的市場趨勢分析、預測,市場熵和以及主要企業的簡介等彙整。

第1章 病毒學市場概要

第2章 摘要整理

第3章 病毒學市場情勢

  • 市場佔有率分析
  • 競爭分析
  • 產品基準
  • 終端用戶簡介
  • 前五名公司的財務分析

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 市場機會
  • 波特的五力分析

第5章 策略分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品及市場生命週期分析
  • 供應商、發行者

第6章 病毒學市場:各類型

  • 診斷試驗
  • 病毒性行為感染管理
  • 抗病毒化療
  • 病毒抑制因素

第7章 病毒學市場:各用途

  • 皮膚、軟組織感染疾病
  • 呼吸道感染疾病
  • 消化器官感染疾病
  • 泌尿道感染
  • 眼感染疾病
  • 中樞神經感染疾病
  • 性感染疾病
  • 周產期感染疾病

第8章 病毒學市場:各終端用戶

  • 醫院
  • 診療所
  • 臨床研究設施
  • 診斷中心
  • 血庫
  • 藥局

第9章 病毒學市場:各地區

  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 英國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 其他地區(RoW)
    • 巴西
    • 其他

第10章 病毒學市場:熵

  • 市場擴大
  • 技術的進步
  • 合併、收購、合資企業
  • 供給、契約

第11章 企業簡介

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Virology is a branch of microbiological or pathological science which involves the study of viruses and virus-like agents. Virology focuses on the following aspects of viruses: their structure, classification and evolution, their ways to infect and exploit host cells for reproduction, their interaction with host organism physiology and immunity, the diseases they cause, the techniques to isolate and culture them, and their use in research and therapy. Globally, increasing instances of viral epidemic breakouts and huge R&D investment by major players are expected to remain key growth drivers for virology during the period of study.

Geographically, North America dominated the virology market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for virology market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the virology market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the virology market.

This report segments the virology market on the basis of type, application, end-user and regional market as follows:

Virology market research report is classified on the basis of type. Some of the major types covered in this report are as follows: Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons

Virology market research report is classified on the basis of application. Some of the major applications covered in this report are as follows: Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infections, Eye Infections, CNS Infections, Sexually Transmitted Diseases, Perinatal Infections

Virology market research report is classified on the basis of end-users. Some of the major end-users covered in this report are as follows: Hospitals, Clinics, Laboratories, Diagnostic Centres, Blood Banks, Pharmacies

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the virology market. Some of the major companies' profiles in detail are as follows:

GlaxoSmithKline plc

Abbott Laboratories

Boehringer Ingelheim Corporation

Merck and Co. Inc.

Novartis International AG

1. Virology Market - Overview

2. Executive Summary

3. Virology Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Virology Market- Forces

  • 4.1. Drivers
    • 4.1.1. Increasing incidences of global viral epidemics
    • 4.1.2. Growing applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Virology Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Virology Market, By Type

  • 6.1. Diagnosing Test
  • 6.2. Viral Infection Controlling Methods
  • 6.3. Antiviral Chemotherapy
  • 6.4. Interferons

7. Virology Market, By Application

  • 7.1. Skin and Soft Tissue Infections
  • 7.2. Respiratory Tract Infections
  • 7.3. GI Tract Infections
  • 7.4. Urinary Tract Infections
  • 7.5. Eye Infections
  • 7.6. CNS Infections
  • 7.7. Sexually Transmitted Diseases
  • 7.8. Perinatal Infections

8. Virology Market, By End-User

  • 8.1. Hospitals
  • 8.2. Clinics
  • 8.3. Laboratories
  • 8.4. Diagnostic Centres
  • 8.5. Blood Banks
  • 8.6. Pharmacies

9. Virology Market, By Geography

  • 9.1. Europe
    • 9.1.1. Germany
    • 9.1.2. France
    • 9.1.3. Italy
    • 9.1.4. Spain
    • 9.1.5. Russia
    • 9.1.6. U.K.
    • 9.1.7. Rest of Europe
  • 9.2. Asia Pacific
    • 9.2.1. China
    • 9.2.2. India
    • 9.2.3. Japan
    • 9.2.4. South Korea
    • 9.2.5. Rest of Asia-Pacific
  • 9.3. North America
    • 9.3.1. U.S.
    • 9.3.2. Canada
    • 9.3.3. Mexico
  • 9.4. Rest of the World (RoW)
    • 9.4.1. Brazil
    • 9.4.2. Rest of RoW

10. Virology Market - Entropy

  • 10.1. Expansion
  • 10.2. Technological Developments
  • 10.3. Merger & Acquisitions, and Joint Ventures
  • 10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 11.1. GlaxoSmithKline plc
  • 11.2. Abbott Laboratories
  • 11.3. Boehringer Ingelheim Corporation
  • 11.4. Merck and Co. Inc.
  • 11.5. Novartis International AG
  • 11.6. Siemens
  • 11.7. Johnson & Johnson
  • 11.8. AstraZeneca AB
  • 11.9. Roche
  • 11.10. Abivax

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top